1. Home
  2. MGLD vs CNXU Comparison

MGLD vs CNXU Comparison

Compare MGLD & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Marygold Companies Inc.

MGLD

The Marygold Companies Inc.

SELL

Current Price

$1.97

Market Cap

84.8M

Sector

Finance

ML Signal

SELL

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

SELL

Current Price

$2.12

Market Cap

92.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MGLD
CNXU
Founded
1996
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.8M
92.8M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
MGLD
CNXU
Price
$1.97
$2.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.8K
★ 273.5K
Earning Date
11-27-2026
02-03-2027
Dividend Yield
N/A
N/A
EPS Growth
★ 28.57
N/A
EPS
★ 0.04
N/A
Revenue
★ $34,876,734.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$49.38
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.84
$1.93
52 Week High
$2.12
$13.66

Technical Indicators

Market Signals
Indicator
MGLD
CNXU
Relative Strength Index (RSI) 72.50 32.47
Support Level $0.93 N/A
Resistance Level $2.12 $4.36
Average True Range (ATR) 0.01 0.29
MACD -0.02 0.04
Stochastic Oscillator 75.00 16.77

Price Performance

Historical Comparison
MGLD
CNXU

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include Fund Management through USCF Investments, Security Systems, Financial Services, Beauty Products, and Corporate Headquarters. The majority of revenue comes from fund management. The company operates in the United States, the United Kingdom, and Canada. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Share on Social Networks: